Complications associated with postoperative adjuvant radiation therapy for advanced rectal cancer

International Surgery

Volumn 99, Issue 2, 2014, Pages 100-105

  Komori, Koji ^a   Kimura, Kenya ^a   Kinoshita, Takashi ^a   Sano, Tsuyoshi ^a   Ito, Seiji ^a   Abe, Tetsuya ^a   Senda, Yoshiki ^a   Misawa, Kazunari ^a   Ito, Yuichi ^a   Uemura, Norihisa ^a   Kawai, Ryosuke ^a   Shimizu, Yasuhiro ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Adjuvant radiation therapy; Advanced rectal cancer; Late complication

Indexed keywords

ADJUVANT RADIOTHERAPY; ADULT; ADVERSE EFFECTS; AGED; CANCER STAGING; EVALUATION STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RECTAL NEOPLASMS; RECTUM; RETROSPECTIVE STUDY; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RECTUM; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84904666308     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: 10.9738/INTSURG-D-13-00200.1     Document Type: Review

References (17)

1. Watanabe T. Chemoradiotherapy and adjuvant chemotherapy for rectal cancer. Int J Clin Oncol 2008; 13(6): 488-497
2. Ishikura S, Ogino T, Ono M et al. Preliminary results of pelvic autonomic nerve-preserving surgery combined with intraoperative and postoperative radiation therapy for patients with low rectal cancer. Jpn J Clin Oncol 1999; 29(9): 429-433
3. Masaki T, Takayama M, Matsuoka H et al. Intraoperative radiotherapy for oncological and function-preserving surgery in patients with advanced lower rectal cancer. Langenbecks Arch Surg 2008; 393(2): 173-180
4. Andre T, Boni C, Navarro M et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. Journal of clinical oncology. J Clin Oncol 2009; 27(19): 3109-3116
5. Doi T, Boku N, Kato K et al. Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer. Jpn J Clin Oncol 2010; 40(10): 913-920
6. Sadahiro S, Suzuki T, Maeda Y et al. Effects of preoperative immunochemoradiotherapy and chemoradiotherapy on immune responses in patients with rectal adenocarcinoma. Anticancer Res 2010; 30(3): 993-999
7. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. National Cancer Institute website. http://www.cancer.gov/. Accessed June 14, 2010.
8. Ishikura S, Nihei K, Ohtsu A et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003; 21(14): 2697-2702
9. Kumekawa Y, Kaneko K, Ito H et al. Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma. J Gastroenterol 2006; 41(5): 425-432
10. Morota M, Gomi K, Kozuka Tet al Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 2009; 75(1): 122-128
11. Henson CC, Andreyev HJ, Symonds RP, Peel D, Swindell R, Davidson SE. Late-onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologists. Clin Oncol (R Coll Radiol) 2011; 23(8): 552-557
12. Zucali R, Gardani G, Volterrani F. Adjuvant postoperative radiotherapy in locally advanced rectal and rectosigmoidal cancer. Tumori 1980; 66(5): 595-600
13. Nose T, Peiffert D, Lapeyre M, Hoffstetter S, Koizumi M, Nishiyama K. Late effects of post-high-dose-rate brachytherapy for oropharyngeal carcinoma: are they severer than post-low-dose-rate? Strahlentherapie und Onkologie: Strahlenther Onkol 2004; 180(12): 776-782
14. Ippolito E, Massaccesi M, Digesu C et al. Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 2012; 83(2): 191-195
15. Fuccio L, Guido A, Laterza L et al. Randomised clinical trial: preventive treatment with topical rectal beclomethasone dipropionate reduces post-radiation risk of bleeding in patients irradiated for prostate cancer. Aliment Pharmacol Ther 2011; 34(6): 628-637
16. Syndikus I, Morgan RC, Sydes MR, Graham JD, Dearnaley DP; MRC RT01 Collaborators. Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397). Int J Radiat Oncol Biol Phys 2010; 77(3): 773-783
17. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg 2008; 95(2): 206-213